Home / Dressings & Wet Gauze

Dressing Selection Principles & Wet Gauze Technique (Professional)

Clinical edition for healthcare professionals ・ 2026.08 condensed edition ・ Compiled from WHS / IWGDF 2023 / EPUAP-NPIAP-PPPIA 2019 / EWMA guidelines; full citations in the Guidelines Library

Core concept: dressings are not the whole treatment of chronic wounds. Diagnose the etiology first, then prepare the wound bed, and finally choose a dressing based on exudate, infection, depth, pain, and periwound skin. What truly determines healing is perfusion, offloading, edema control, infection control, and systemic care (IWGDF 2023; WHS 2023–2024).

1. Assessment before dressing selection

Shared principle across guidelines: dressing selection must be built on standardized assessment, not on defaulting to a product (EPUAP/NPIAP/PPPIA 2019; IWGDF 2023).

Assessment domain	Impact on dressing choice
Etiology (diabetic foot / pressure / arterial / venous / radiation / malignancy)	Determines the need for offloading, compression, vascular assessment, biopsy, or palliative care
Perfusion (pulses, ABI/TBI, toe pressure)	Do not rashly apply moist dressings to dry black eschar or debride aggressively in arterial ischemic wounds (WHS Arterial Ulcers 2024)
Infection (erythema, swelling, warmth, pain, pus, fever, cultures)	Determines antimicrobial dressings, debridement, antibiotics, or surgery; uninfected ulcers do not need antibiotics (IWGDF/IDSA 2023)
Exudate (volume, character, strike-through speed)	Determines absorbency, dressing-change frequency, and periwound skin protection
Depth and dead space (undermining, sinus tracts, exposed tendon or bone)	Determines packing, NPWT, or further debridement
Pain / bleeding, periwound skin	Determines non-adherent or silicone contact layers, skin barrier film, and low-trauma fixation

2. Bedside mnemonic and selection workflow

Wound dressing selection flowchart: assess the wound, seek medical care for infection/ischemia/deep wounds, then select by exudate level — Figure: dressing selection workflow — safety first (infection / ischemia / deep wounds need medical care), then select by exudate level (click to enlarge)

Rule	Dressing direction
Dry: rehydrate	Hydrogel, non-adherent; assess perfusion first for dry black ischemic eschar
Wet: absorb	Foam, alginate, hydrofiber, superabsorbent dressings
Dirty: debride	Decide the debridement method first (see debridement decisions); dressings are only adjuncts
Odor: control bioburden	Antimicrobial dressings, activated charcoal; systemic therapy when needed
Deep: pack loosely	Alginate rope / hydrofiber ribbon; never pack tightly, and ensure complete retrieval
Painful: non-adherent	Silicone contact layer, non-adherent dressings, low-tack fixation
Protect periwound skin	Skin barrier film, increased absorbency, low-allergenic fixation
Ischemic: assess perfusion first	Vascular assessment and referral first (SVS/GVG 2019)

1. First rule out critical ischemia and severe infection — cold foot, rest pain, dry black eschar, gangrene, or systemic signs of infection: address perfusion and infection first.

↓

2. Judge exudate volume — dry wounds need rehydration; moderate-to-heavy exudate needs absorption; a sudden increase in exudate warrants reassessment of infection, edema, and venous hypertension.

↓

3. Judge depth and dead space — deep cavities, undermining, and sinus tracts need light packing with confirmed retrieval.

↓

4. Consider pain, bleeding, and periwound skin — non-adherent / silicone contact layer; for maceration, increase absorbency and protect the skin.

↓

5. Set the dressing-change frequency and follow-up — no improvement in 2–4 weeks: reassess the etiology (WHS; IWGDF 2023).

For the functions, indications, limitations, and brand reference of each dressing category, see the Dressing Center; for interactive selection, see the Dressing Selector. In practice, use a layered combination of "contact layer + absorbent layer + fixation layer" rather than seeking a single all-in-one product.

3. Dressing directions by etiology (summary)

Wound type	Dressing direction	Etiologic priority (guideline core)
Diabetic foot	Non-adherent, foam, hydrofiber, alginate; pack deep cavities	Offloading and vascular assessment matter more than the dressing; rule out osteomyelitis (IWGDF 2023)
Venous ulcer	Foam, superabsorbent, alginate, hydrofiber	Compression therapy is the cornerstone; confirm arterial perfusion before compressing (WHS 2016; EWMA 2023)
Arterial ulcer	Dry black eschar without infection → keep dry and protect; low exudate → non-adherent	Perfusion first; never debride ischemic eschar indiscriminately (WHS 2024)
Pressure injury	Silicone foam, alginate, hydrofiber; NPWT when indicated	Pressure redistribution is the cornerstone; choose dressings by stage (EPUAP/NPIAP/PPPIA 2019; see the reference table)
Radiation / malignant wounds	Non-adherent, silicone contact layer, superabsorbent, activated charcoal	Exclude recurrence; for malignant wounds the goals are exudate control, odor control, hemostasis, and pain relief (EWMA 2025)

4. Dressing-change frequency and reassessment

Situation	Frequency direction
Infection, heavy pus, close observation required	Daily or more frequently
Heavy exudate, easy strike-through	Change earlier at strike-through + increase absorbency
Moderate, stable exudate	Every 2–3 days
Clean, low exudate / near healing	Extend the interval; minimize traction to protect new epithelium

Change earlier if the dressing leaks, loosens, or is contaminated; sudden increase in pain, malodor, spreading erythema, or fever → reassess for infection
Periwound maceration → increase absorbency, shorten the interval, apply a skin barrier film
No clear improvement in 2–4 weeks → reassess perfusion, infection, pressure, nutrition, malignant transformation, and the dressing strategy
Antimicrobial dressings are for time-limited use with reassessment at 1–2 weeks, not routine prophylaxis (IWGDF/IDSA 2023)

5. Common errors (safety bottom lines)

Erroneous practice	Suggested correction
Using the same dressing for every chronic wound	Reselect according to etiology and wound-bed status
Changing dressings without assessing perfusion / no offloading for diabetic feet / no edema control for venous ulcers	Return to etiologic treatment: vascular assessment, off-loading, compression, and elevation
Treating infected wounds with silver dressings alone	Manage by infection severity; do not delay debridement, cultures, and systemic antibiotics
Covering only the surface of deep cavities / packing too tightly	Pack loosely and appropriately, confirm retrieval, and track depth
Applying moist dressings to, or debriding, dry black ischemic eschar indiscriminately	Assess perfusion first; refer to vascular surgery when needed
Long-standing non-healing wounds still not biopsied	Consider biopsy when the appearance is atypical or the edges are raised and bleed easily

Safety bottom line: never let the dressing mask signs of deterioration. If the wound becomes larger, deeper, or malodorous, pain intensifies, tissue turns black, or the patient's general condition worsens, reassess immediately. Every dressing change is a reassessment.

6. Technique: Wet Gauze Dressing — principles of use in wounds requiring debridement

Core conclusion: moist gauze may be used short-term to soften slough, provide temporary coverage, and assist autolytic debridement; do not treat wet-to-dry — ripping off gauze after it has dried — as routine debridement for chronic wounds (Wodash 2013; WHS 2023).

1. Distinguish the two techniques first

Technique	Primary purpose	Clinical appraisal
Moist gauze / wet-to-moist Moist gauze / wet-to-moist	Maintain moisture, soften slough, assist autolytic debridement	May be used short-term with adequate perfusion and a clearly defined goal; the gauze should still be moist at removal to avoid injuring granulation tissue.
Wet-to-dry Wet-to-dry	Gauze is removed after drying, producing non-selective mechanical debridement	Generally not recommended for routine use; it may remove necrotic tissue, healthy granulation, and new epithelium indiscriminately.

2. Three mandatory judgments before debridement

(1) Does the wound have the capacity to heal? Assess tissue perfusion first (especially foot, heel, and lower-limb wounds); obtain ABI, TBI, toe pressure, or vascular imaging when needed. Consider active debridement only when perfusion is adequate, healing is possible, and necrotic tissue is impeding healing or infection control.

Important contraindications: critical ischemia, not yet revascularized, dry gangrene, or a stable, dry, intact eschar without signs of infection on an ischemic toe or heel — as a rule, keep it dry, protect it, and perform vascular assessment first; do not soften it with moist dressings or debride it indiscriminately.

(2) What type of tissue needs to be removed? Thin, loose slough → short-term moist softening is reasonable; thick adherent necrosis → moist gauze alone is insufficient, evaluate sharp / surgical / enzymatic debridement; healthy granulation / new epithelium → avoid wet-to-dry, switch to a non-adherent dressing; abscess or deep infection → moist dressings cannot replace incision and drainage and anti-infective therapy; dry ischemic eschar → keep dry and address perfusion first.

(3) Is the debridement goal explicit? Softening and removing loose slough, reducing bacterial and biofilm burden, establishing an environment for granulation, and revealing the true wound depth.

3. Key points of technique

Assess pain, perfusion, infection, bleeding risk, depth, and exposed structures; provide analgesia first when needed
Low-pressure irrigation with sterile 0.9% saline; remove loose slough, never forcibly pull adherent tissue
Wring the gauze to moist but not dripping; apply gently and pack cavities loosely — do not pack tightly, leave no fragments, and never pack blindly into sinus tracts whose base cannot be seen
Add an absorbent secondary dressing and protect the periwound skin; change before the gauze dries out completely; if it has adhered, moisten it first before removal
Document tissue proportions, exudate, odor, pain, dimensions, and periwound skin at every change

4. Change frequency and when to stop

Clinical situation	Recommended principle
Low exudate with moisture maintainable	Usually once daily
Moderate exudate or close observation needed	1–2 times daily
Heavy exudate, contamination, or infection surveillance	2–3 times daily; frequent saturation → switch to a superabsorbent dressing
Dried out, saturated, leaking, dislodged, or soiled by feces/urine	Change immediately
Requiring 3–4 changes daily just to stay moist or contain leakage	Moist gauze is unsuitable for long-term use; reselect the dressing

When to stop or switch: the wound bed is predominantly healthy granulation or beginning to epithelialize; slough has not decreased or size has not improved after 1–2 weeks; recurrent pain, bleeding, or granulation injury at dressing changes; periwound skin becomes macerated, blanched, or eroded; the wound enlarges, deepens, or exposes deep structures; suspicion of ischemia, cellulitis, abscess, osteomyelitis, or systemic infection; exudate exceeds the absorptive capacity of gauze.

5. Clinical decision mnemonic (four steps)

First determine whether debridement is appropriate (perfusion and healing potential) → then identify which tissue must be removed → choose the most selective, least traumatic method → and stop or switch dressings promptly according to changes in granulation, exudate, and infection.

Moist gauze is a local care tool — it cannot replace pressure redistribution, compression therapy, revascularization, infection control, nutrition, or glycemic management. Seek immediate medical evaluation for spreading erythema, warmth, and pain; foul purulent discharge; fever; rapidly expanding necrosis; crepitus; a cold pale foot; or a sudden surge in pain.

Sources (see the Guidelines Library): IWGDF Guidelines 2023 (DOI:10.1002/dmrr.3644 series); IWGDF/IDSA Infection Guideline 2023 (DOI:10.1093/cid/ciad527); Gould LJ, et al. WHS Pressure Ulcers 2023 update (WRR 2024, DOI:10.1111/wrr.13130); Federman DG, et al. WHS Arterial Ulcers 2023 update (WRR 2024, DOI:10.1111/wrr.13204); Marston W, et al. WHS Venous Ulcers (WRR 2016, DOI:10.1111/wrr.12394); EPUAP/NPIAP/PPPIA International Guideline 2019; EWMA Lower Leg Ulcer 2023 / Palliative 2025; Conte MS, et al. Global Vascular Guidelines (JVS 2019, DOI:10.1016/j.jvs.2019.02.016); Wodash AJ 2013 (wet-to-dry evidence).

Last updated: 2026-08-31 ・ 2026.08 condensed edition (compiled from society guidelines in the Guidelines Library)